Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Graham G. Walmsley Insider Profile
11 Followers
Graham G. Walmsley, Director at Akero Therapeutics, holds 708.11K shares in Olema Pharmaceuticals (Ticker: OLMA), holds 802.17K shares in Akero Therapeutics (Ticker: AKRO), holds 3.16M shares in ALX Oncology Holdings (Ticker: ALXO). Most recently, Graham G. Walmsley Sold ― shares of Olema Pharmaceuticals on Jun 06, 2024 for an estimated value of 17.45M.
Profitable Transactions
3 out of 10 Profitable Transactions
Average Return
-19.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Graham G. Walmsley holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 21, 2020 - Jul 21, 2021
Return:+89.70%
The most profitable trade made by Graham G. Walmsley
Graham G. Walmsley's Trading History
Akero Therapeutics
Dec 11, 2023
Director
Informative Buy
1.98M
$19.48M
ALX Oncology Holdings
Dec 15, 2020
Director
Informative Buy
1.52M
$26.93M
Olema Pharmaceuticals
Jun 06, 2024
Director
Informative Sell
17.45M
$9.11M
List of latest transactions for each holding click on a transaction to see Graham G. Walmsley's performance on stock
You May Also Like
Graham G. Walmsley insider profile FAQ
What is the percentage of profitable transactions made by Graham G. Walmsley?
The percentage of profitable transactions made by Graham G. Walmsley is 30%.
What is the average return per transaction made by Graham G. Walmsley?
The average return per transaction made by Graham G. Walmsley is -19.00%.
What stocks does Graham G. Walmsley hold?
Graham G. Walmsley holds: AKRO, ALXO, OLMA stocks.
What was Graham G. Walmsley’s latest transaction?
Graham G. Walmsley latest transaction was an Informative Sell of $17.45M.
What was Graham G. Walmsley's most profitable transaction?
Graham G. Walmsley’s most profitable transaction was an Informative Buy of ALXO stock on July 21, 2020. The return on the trade was 89.70%.
What is Graham G. Walmsley's role in Akero Therapeutics?
Graham G. Walmsley's role in Akero Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.